
Alcidion Group
Alcidion Group Limited is a provider of cutting-edge informatics software tailored for high-performance healthcare services. The company leverages advanced technology to enhance patient outcomes and operational efficiency in hospitals and health systems. Positioned as a leader in clinical process improvement and workflow management, Alcidion offers a unique value proposition with its smart, integrated healthcare solutions.
Short position
Alcidion Group (ASX:ALC) has 0.00% of its shares on issue reported as short positions as of 5 Oct 2026, or about 852 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.65% in December 2021. ALC is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Alcidion Group (ALC) short interest history
ALC Short Interest History
- 30-day change
- -0.00pp
- 90-day change
- -0.00pp
- 1-year change
- -0.05pp
- All-time high
- 0.65% (December 2021)
- All-time low
- 0.00% (April 2026)
Is ALC heavily shorted?
Not especially: 0.00% short interest is modest by ASX standards, ranking #748 of 799 ASX securities with reported short positions. ASIC requires positions of 0.01% of issued capital or $100,000 (whichever is less) to be reported.
How has ALC's short interest changed recently?
Over the past 30 days Alcidion Group's short interest has been broadly stable, and over 90 days it has been broadly stable. The current level is 0.00% of shares on issue.
What is the highest ALC's short interest has been?
Since 2017, Alcidion Group's short interest peaked at 0.65% in December 2021 and bottomed at 0.00% in April 2026.
Where does this data come from?
All figures are sourced from daily ASIC short position reports, published with a four trading-day (T+4) delay. Shorted aggregates the full history since 2017. See our methodology.